In conclusion, both the glucocorticoid methylprednisolone, and the novel selective GR modulator compound A display anti-inflammatory actions in both ex vivo PBMC and a nasal tissue stimulation model of nasal polyposis. This evidence concerns the gene NR3C1 and Nasal polyposis.